View of Necrostatin-1 as a Neurogenic Agent to Ameliorate the Neurogenesis and Motor Outcomes in Neonatal Hypoxic-Ischemic Encephalopathy Through RIP1 Inhibition: A Research Protocol

Return to Article Details Necrostatin-1 as a Neurogenic Agent to Ameliorate the Neurogenesis and Motor Outcomes in Neonatal Hypoxic-Ischemic Encephalopathy Through RIP1 Inhibition: A Research Protocol Download Download PDF